Across TCGA pan-cancer cohorts, LINC01248 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01248’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01248 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01248 is over-expressed in tumor.

BRCA, LUSC, and HNSC are the cancer types where LINC01248 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01248 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.036	.034	4	view →
LUSC	All	All	+0.051	.035	1	view →
HNSC	All	All	+0.043	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC01248 RNA expression & survival · all LINC01248 data types